The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Core Laboratories NV

NYSE: CLB
Last

(U.S.) $122.26

Today's change+3.07 +2.58%
Updated December 19 4:07 PM EST. Delayed by at least 15 minutes.
 

Core Laboratories NV

NYSE: CLB
Last

(U.S.) $122.26

Today's change+3.07 +2.58%
Updated December 19 4:07 PM EST. Delayed by at least 15 minutes.

Core Laboratories NV up sharply

Core Laboratories NV closed up sharply Friday, rallying (U.S.)$3.07 or 2.58% to (U.S.)$122.26. Over the last five days, shares have gained 8.66%, but are down 35.97% for the last year to date. Shares have underperformed the S&P 500 by 50.87% during the last year.

Key company metrics

  • Open(U.S.) $120.00
  • Previous close(U.S.) $119.19
  • High(U.S.) $122.78
  • Low(U.S.) $118.22
  • Bid / Ask-- / --
  • YTD % change-35.97%
  • Volume1,190,102
  • Average volume (10-day)1,070,623
  • Average volume (1-month)906,256
  • Average volume (3-month)706,543
  • 52-week range(U.S.) $109.88 to (U.S.) $221.00
  • Beta0.92
  • Trailing P/E21.48×
  • P/E 1 year forward21.00×
  • Forward PEG1.31×
  • Indicated annual dividend(U.S.) $2.00
  • Dividend yield1.64%
  • Trailing EPS(U.S.) $5.69
Updated December 19 4:07 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+23.70%

Based on its net profit margin of 23.70%, Core Laboratories NV is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.85%Sector:EnergyIndustry:Oil Related Services & Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue276268263276
Total other revenue--------
Total revenue276268263276
Gross profit10999101108
Total cost of revenue167168162168
Total operating expense187183180188
Selling / general / administrative12111013
Research & development--------
Depreciation / amortization7677
Interest expense (income), net operating--------
Unusual expense (income)000-1
Other operating expenses, total0000
Operating income89848388
Interest income (expense), net non-operating-3-3-2-2
Gain (loss) on sale of assets--------
Other--------
Income before tax87818085
Income after tax67646165
Income tax, total20171921
Net income66646165
Total adjustments to net income--------
Net income before extra. items66646165
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items66646165
Inc. avail. to common incl. extra. items66646165
Diluted net income66646165
Dilution adjustment--------
Diluted weighted average shares44454546
Diluted EPS excluding extraordinary itemsvalue per share1.501.421.351.42
Dividends per sharevalue per share0.500.500.500.32
Diluted normalized EPSvalue per share1.491.421.351.41